STAB
Statera Biopharma, Inc. Common Stock
STAB
STAB
Delisted
STAB was delisted on the 11th of January, 2023.
29 hedge funds and large institutions have $4.64M invested in Statera Biopharma, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
97% less call options, than puts
Call options by funds: $1K | Put options by funds: $36K
Holders
29
Holding in Top 10
–
Calls
$1K
Puts
$36K
Top Buyers
| 1 | +$354K | |
| 2 | +$211K | |
| 3 | +$132K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$122K |
| 5 |
BlackRock
New York
|
+$96K |
Top Sellers
| 1 | -$45K | |
| 2 | -$32K | |
| 3 | -$29K | |
| 4 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$27.6K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$20.7K |